TRVI Operating Cash Flow (Statement)

Trevi Therapeutics Inc · Operating Cash Flow (Statement)

TRVI logo

TRVI Operating Cash Flow (Statement)

Latest reported-$52.63M
TRVI TTM Cash from Operations (-$18.29M → -$52.63M)
High-resolution chart · PNG

TRVI operating cash flow (statement) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Trevi Therapeutics Inc Operating Cash Flow (Statement) — Trailing twelve months (TTM) (USD)
Period endingOperating Cash Flow (Statement) (USD)
-52,629,000
-45,301,000
-42,089,000
-44,008,000
-42,684,000
-41,266,000
-38,256,000
-35,065,000
-32,788,000
-33,980,000
-31,710,000
-31,682,000
-32,979,000
-29,280,000
-28,175,000
-28,073,000
-26,738,000
-28,460,000
-28,946,000
-31,641,000
-31,367,000
-31,905,000
-29,000,000
-26,278,000
-27,045,000
-23,670,000
-23,093,000
-21,625,000
-17,884,000
-18,433,000
-18,291,000
-13,559,834
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.